Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Contractor Nightmares (and How to Avoid Them)
- No one foresees workplace nightmares. But when you hire contract workers, they're even more likely to occur. The Disappearing Contractor Barring, say,...
- Articles 2009-08-17
Additional Resources
- Find me a partner, please! Firms cite drug distribution problems for earning declines
- Two pharmaceutical companies made public what is usually confidential searches for marketing partners. Centocor Inc. and Novo-Nordick A/S both said that 1997 earnings will fall below expectations due, in part, to the need for business alliances. Centocor seeks a European distribution agreement with an upfront payment for its genetically...
- Research articles 1998-01-01
- Genzyme?s Problems Continue
- Zacks.com submits: Genzyme Corp. GENZ suffered a setback last week when Shire Plc. SHPGY announced positive phase III results on velaglucerase alfa, an enzyme replacement therapy, which is being developed for the treatment of Gaucher disease. Shire has initiated the process of submitting its New Drug...
- External links 2009-08-09
- J&J Settles Fatal Patch Cases, So Why Is This Thing Still on the Market?
- Johnson & Johnson has paid $68 million to settle hundreds of cases brought by women who used the Ortho Evra birth control patch. The settlements raise a question: Why is this patch still on the market when it is now well-established that its risk of causing fatal blood clots is...
- Blog posts 2008-10-10
- ISIS Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. We'll go to Adam Walsh with Jefferies. Adam Walsh - Jefferies Good morning, guys, thanks for taking my question. I assume you can hear me. Stan Crooke Yes. Thank you. Adam Walsh - Jefferies Wonderful and Stan, we've been over this before. Maybe you could...
- Earnings calls 2008-11-10
- Medivation Inc. Q3 2008 Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions We’ll take our first question from Kim Lee with Pacific Growth Equities. Kim Lee – Pacific Growth Equities Good afternoon. Thanks for taking my questions. The first couple of questions have to do with the Dimebon program. Just wanted to get a clarification,...
- Earnings calls 2008-11-10
- Transit project linking India's major metropolitan areas a year behind schedule.
- The Economic Times, India Knight Ridder/Tribune Business News Dec. 1--BANGALORE, India -- The golden quadrilateral GQ project linking the four metros and other major cities across 13 states at a cost of Rs 34,300 crore will be delayed by a year and completed...
- Research articles 2004-12-01
- Protalix Wins Orphan Drug Status for Gaucher Disease Treatment
- Zacks.com submits: On Tuesday, Protalix BioTherapeutics, Inc. PLX announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to prGCD for the treatment of Gaucher disease, an enzyme disorder that can cause liver and neurological problems. The drug is currently being evaluated in a...
- External links 2009-09-10
- Genzyme: Contents Under Pressure
- Friday's announcement that bits of rubber and other detritus were found in vials of five different drugs manufactured at Genzyme's beleaguered Allston Landing plant was worthy of the satirical publication "The Onion"--except that it was true.The picture grew murkier over the weekend, with the arrival of another Form 483 missive...
- News items 2009-11-18
- << Previous
- page 1 of 1
- Next >>
